Prednisone Tapering Guidelines

Introduction to Tapering

The American College of Rheumatology recommends a two-phase approach to taper prednisone: reduce to 10 mg/day within 4-8 weeks, then decrease by 1 mg every 4 weeks until discontinuation, while monitoring closely for both disease relapse and adrenal insufficiency 1, 2, 3

The European League Against Rheumatism suggests reducing prednisone to 10 mg/day within 4-8 weeks, regardless of starting dose, to minimize adrenal suppression risk and adverse effect burden 1, 2, 3
For doses above 10 mg/day, the tapering schedule is as follows:
Once at 10 mg/day, reduce by 1 mg every 4 weeks until complete discontinuation, as small dose decrements below 10 mg can trigger significant withdrawal symptoms 1, 2, 3, 4, 5

The American College of Rheumatology recommends monitoring patients every 4-8 weeks during the first year of tapering, then every 8-12 weeks in the second year, assessing disease activity markers, signs of adrenal insufficiency, withdrawal symptoms, and corticosteroid-related adverse effects 1, 2, 3
If disease relapse occurs, immediately return to the pre-relapse dose and maintain for 4-8 weeks until disease control is re-established, then resume tapering by gradually decreasing to the dose at which relapse occurred over 4-8 weeks 1, 2, 3

Patients with comorbidities require more cautious tapering with closer monitoring, slower taper rates, and more frequent monitoring of blood pressure, glucose, and bone density 3, 6
Patients with recurrent relapses may require indefinite low-dose maintenance (2.5-7.5 mg/day), which is acceptable when benefits outweigh risks 3, 4, 5

Any patient receiving >7.5 mg daily for >3 weeks requires stress-dose coverage during acute illness or surgery due to HPA axis suppression, with hydrocortisone 50 mg twice daily for 3 days for moderate stress/illness and hydrocortisone 50 mg three times daily for severe stress/major surgery 3